SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-15-002045
Filing Date
2015-05-20
Accepted
2015-05-20 16:04:08
Documents
12
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 VG LIFE SCIENCES INC. vglife_10q-033115.htm 10-Q 367026
2 CONSULTING SERVICES AGREEMENT vglife_10q-ex10175.htm EX-10.175 17522
3 MEMORANDUM OF UNDERSTANDING vglife_10q-ex10176.htm EX-10.176 9546
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER vglife_10q-ex3101.htm EX-31.1 8247
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER vglife_10q-ex3102.htm EX-31.2 8053
6 CERTIFICATION vglife_10q-ex3201.htm EX-32.1 4189
  Complete submission text file 0001019687-15-002045.txt   1590510

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE vgls-20150331.xml EX-101.INS 102620
8 XBRL SCHEMA FILE vgls-20150331.xsd EX-101.SCH 14830
9 XBRL CALCULATION FILE vgls-20150331_cal.xml EX-101.CAL 31215
10 XBRL DEFINITION FILE vgls-20150331_def.xml EX-101.DEF 32319
11 XBRL LABEL FILE vgls-20150331_lab.xml EX-101.LAB 110038
12 XBRL PRESENTATION FILE vgls-20150331_pre.xml EX-101.PRE 86974
Mailing Address 121 GRAY AVENUE, SUITE 200 SANTA BARBARA CA 93101
Business Address 121 GRAY AVENUE, SUITE 200 SANTA BARBARA CA 93101 805-879-9000
VG Life Sciences Inc. (Filer) CIK: 0001091326 (see all company filings)

IRS No.: 330814123 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26875 | Film No.: 15879638
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1